and have the potential to eliminate many life-threatening diseases today, and this is the opportunity due to technology, commitment and knowledge if to accelerate, not decelerate our work, and we can eliminate many of these life-threatening diseases in the next few years if we can stay with it. those countries that are the leaders in bioscience will be the leaders in the 21st century. we saw and in the 22nd century, for sure. and, therefore, our commitment to bioscience today is essential. and it s not just that. we have a shortage of 1 million nurses in america today, and this has placed an enormous challenge on our health care delivery system. and you see organizations such as cleveland clinic and and others, they re losing hundreds of millions or billions of
and have the potential to eliminate many life-threatening diseases today, and this is the opportunity due to technology, commitment and knowledge if to accelerate, not decelerate our work, and we can eliminate many of these life-threatening diseases in the next few years if we can stay with it. those countries that are the leaders in bioscience will be the leaders in the 21st century. we saw and in the 22nd century, for sure. and, therefore, our commitment to bioscience today is essential. and it s not just that. we have a shortage of 1 million nurses in america today, and this has placed an enormous challenge on our health care delivery system. and you see organizations such as cleveland clinic and and others, they re losing hundreds of millions or billions of
The upcoming BioFest week will feature a pitch competition that will bring in potential investors from across the nation for Texas bioscience companies looking for funding. Heather Hanson, president of BioMedSA, spoke with KSAT to discuss the event taking place on April 19.